Medical Health & Life Science Research News

Report explores the Global biomarkers market future growth by 2024

Report explores the Global biomarkers market future growth by 2024

Global Biomarkers Market, By Product Type (Consumables, Services, Softwares), Technology (Efficacy, Safety, Validation), Application (Diagnostics, Drug Discovery, Personalized Medicine, Disease Risk Assessment), Indication (Cancer, Cardiovascular, Immunological), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

- Advertising -

Global Biomarkers Market is expected to reach USD 78.9 billion by 2024, from USD 31.4 billion in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024.

For a Free Sample [email protected] databridgemarketresearch.com/reque…biomarkers-market

Some of the major players operating in this market are

  • QIAGEN
  • PerkinElmer, Inc.
  • Merck & Co.
  • Bio-Rad Laboratories Inc.
  • Enzo Biochem Inc.
  • EKF Diagnostics Holdings Plc
  • Abbott
  • Siemens AG
  • MESO SCALE DIAGOSTICS, LLC
  • Agilent Technologies
  • Singulex, Inc.
  • Cisbio Bioassays
  • Thermo Fisher Scientific Inc.
  • Bruker
  • Biosims Technologies
  • Epigenomics AG
  • Signosis, Inc.
  • GE Healthcare

The market is segmented on the basis of type, technology, application, indication, and geography.

Read more @ databridgemarketresearch.com/repor…iomarkers-market/

On the basis of types, the market is segmented into consumables, services, and softwares. The consumables item is expected to represent the largest share in 2016 with the attribution of higher frequency of purchase of consumables as compared to other product segments and expanding utilization of unit based items for the testing of biomarkers.

- Advertising -

Based on technology, the biomarkers marketis segmented into efficacy, safety and validation biomakers. Safety biomarkers segment represented the largest share of the global biomarkers market in 2016.

It is basically used in trial phases 1 and 2, which enables as a proof of toxicity in candidate drug molecules, helps in the expansion in research and development activities and validate new candidate therapeutic products

On the basis of application, global biomarkers market is segmented into diagnostics, drug discovery, personalized medicine and disease risk assessment. Diagnostics segment accounted the highest market share in 2016.

Biomarkers assume a critical part in the treatment of different diseases. Accordingly diagnostics improvement has major biomarker application compared with different applications because of expanding healthcare expenditure, which is enhancing access to new and top notch diagnostics, and supporting development of the diagnostics application segment.

Based on indication, the market is segmented into cancer, cardiovascular disorders, and immunological disorders.

Based on geography the global biomarkers market report is segmented into 5 major countries such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

Access report:  http:/databridgemarketresearch.co…iomarkers-market

Table Of Content:

1.INTRODUCTION

1.1.OVERVIEW OF THE GLOBAL BIOMARKERS MARKET

1.2.MARKET SEGMENTATION & COVERAGE

1.2.1.CURRENCY AND PRICING

1.2.2.LIMITATION

1.2.3.STAKEHOLDERS

2.RESEARCH METHODOLOGY

2.1.KEY TAKEAWAYS

2.2.ARRIVING AT THE GLOBAL BIOMARKERS MARKET SIZE

2.2.1.MARKET CRACKDOWN APPROACH

2.2.2.COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3.DATA TRIANGULATION

2.2.4.KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.PRODUCT PIPELINE ANALYSIS

2.2.6.PORTER’S FIVE FORCES MATRIX

2.3.GLOBAL BIOMARKERS MARKET: RESEARCH SNAPSHOT

2.4.ASSUMPTIONS

3.MARKET LANDSCAPE SUMMARY

4.PREMIUM INSIGHTS

4.1.OVERVIEW

4.2.GLOBAL BIOMARKERS MARKET: KEY PRIMARY INSIGHTS

4.3.MARKET OVERVIEW

4.3.1.DRIVERS

4.3.1.1.INCREASING HEALTHCARE EXPENDITURE

4.3.1.2.NON-INVASIVE

4.3.1.3.LOW-COST FOR CONDUCTING CLINICAL TRIALS

4.3.1.4.GROWING NUMBER OF CROs

4.3.2.RESTRAINTS

4.3.3.OPPURTUNITIES

4.3.4.THREATS

4.4.KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5.EXECUTIVE SUMMARY

6.BIOMARKERS MARKET, BY PRODUCT TYPE

6.1.OVERVIEW

6.2.CONSUMABLES,

6.3.SERVICES,

6.4.SOFTWARE,

7.BIOMARKERS MARKET, BY TECHNOLOGY

7.1.OVERVIEW

7.2.SAFETY BIOMARKERS

7.3.EFFICACY BIOMARKERS

7.4.VALIDATION BIOMARKERS

8.BIOMARKERS MARKET, BY APPLICATION

8.1.    OVERVIEW

8.2.    DIAGNOSTICS DEVELOPMENT

8.3.    DRUG DISCOVERY AND DEVELOPMENT

8.4.    PERSONALIZED MEDICINE

8.5     DISEASE-RISK ASSESSMENT

8.6.    OTHERS

9.BIOMARKERS MARKET, BY INDICATION

9.1.OVERVIEW

9.2.CANCER

9.3.CARDIOVASCULAR DISORDERS

9.4.NEUROLOGICAL DISORDERS

9.5.IMMUNOLOGICAL DISORDERS

9.6.OTHER DISEASES

10.BIOMARKERS MARKET, BY GEOGRAPHY

10.1.COUNTRYWISE DRUG DELIVERY DEVICES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

10.1.1.NORTH AMERICA

10.1.1.1.U.S.

10.1.1.2.CANADA

10.1.1.3.MEXICO

10.1.2.EUROPE

10.1.2.1.GERMANY

10.1.2.2.FRANCE

10.1.2.3.U.K.

10.1.2.4.ITALY

10.1.2.5.SPAIN

10.1.2.6.RUSSIA

10.1.2.7.TURKEY

10.1.2.8.BELGIUM

10.1.2.9.NETHERLANDS

10.1.2.10.SWITZERLAND

10.1.2.11.REST OF EUROPE

10.1.3.ASIA-PACIFIC (APAC)

10.1.3.1.JAPAN

10.1.3.2.CHINA

10.1.3.3.SOUTH KOREA

10.1.3.4.INDIA

10.1.3.5.AUSTRALIA

10.1.3.6.SINGAPORE

10.1.3.7.THAILAND

10.1.3.8.MALAYSIA

10.1.3.9.INDONESIA

10.1.3.10.PHILIPPINES

10.1.3.11.REST OF APAC

10.1.4.LATIN AMERICA

10.1.4.1.BRAZIL

10.1.4.2.REST OF LATIN AMERICA

10.1.5.MIDDLE EAST AND AFRICA

10.1.5.1.SOUTH AFRICA

10.1.5.2.REST OF MIDDLE EAST AND AFRICA

10.2.KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

11.BIOMARKERS MARKET: COMPETITIVE LANDSCAPE

11.1.GLOBAL BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.2.U.S. BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.3.EUROPE BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.4.APAC BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.5.SOUTH AMERICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.6.MIDDLE EAST AND AFRICA BIOMARKERS MARKET: COMPANY SHARE ANALYSIS

11.7.MERGERS & ACQUISITIONS

11.8.NEW PRODUCT DEVELOPMENT & APPROVALS

11.9.EXPANSIONS

11.10.REGULATORY CHANGES

11.11.PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

12.BIOMARKERS MARKET, COMPANY PROFILES

12.1.QIAGEN N.V

12.1.1.COMPANY OVERVIEW

12.1.2.SWOT ANALYSIS

12.1.3.REVENUE ANALYSIS

12.1.4.PRODUCT PORTFOLIO

12.1.5.RECENT DEVELOPEMENTS

12.1.6.DATA BRIDGE ANALYSIS

12.2.PERKINELMER, INC

12.2.1.COMPANY OVERVIEW

12.2.2.SWOT ANALYSIS

12.2.3.REVENUE ANALYSIS

12.2.4.PRODUCT PORTFOLIO

12.2.5.RECENT DEVELOPEMENTS

12.2.6.DATA BRIDGE ANALYSIS

12.3.MERCK & CO, INC.

12.3.1.COMPANY OVERVIEW

12.3.2.SWOT ANALYSIS

12.3.3.REVENUE ANALYSIS

12.3.4.PRODUCT PORTFOLIO

12.3.5.RECENT DEVELOPEMENTS

12.3.6.DATA BRIDGE ANALYSIS

12.4.BIO-RAD LABORATORIES

12.4.1.COMPANY OVERVIEW

12.4.2.SWOT ANALYSIS

12.4.3.REVENUE ANALYSIS

12.4.4.PRODUCT PORTFOLIO

12.4.5.RECENT DEVELOPEMENTS

12.4.6.DATA BRIDGE ANALYSIS

12.5.ENZO BIOCHEM, INC.,

12.5.1.COMPANY OVERVIEW

12.5.2.SWOT ANALYSIS

12.5.3.REVENUE ANALYSIS

12.5.4.PRODUCT PORTFOLIO

12.5.5.RECENT DEVELOPEMENTS

12.5.6.DATA BRIDGE ANALYSIS

12.6.EKF DIAGNOSTICS HOLDINGS, PLC

12.6.1.COMPANY OVERVIEW

12.6.2.SWOT ANALYSIS

12.6.3.REVENUE ANALYSIS

12.6.4.PRODUCT PORTFOLIO

12.6.5.RECENT DEVELOPEMENTS

12.6.6.DATA BRIDGE ANALYSIS

12.7.MESO SCALE DIAGNOSTICS

12.7.1.COMPANY OVERVIEW

12.7.2.SWOT ANALYSIS

12.7.3.REVENUE ANALYSIS

12.7.4.PRODUCT PORTFOLIO

12.7.5.RECENT DEVELOPEMENTS

12.7.6.DATA BRIDGE ANALYSIS

12.8.LLC, SINGULEX, INC.,

12.8.1.COMPANY OVERVIEW

12.8.2.SWOT ANALYSIS

12.8.3.REVENUE ANALYSIS

12.8.4.PRODUCT PORTFOLIO

12.8.5.RECENT DEVELOPEMENTS

12.8.6.DATA BRIDGE ANALYSIS

12.9.CISBIO BIOASSAYS

12.9.1.COMPANY OVERVIEW

12.9.2.SWOT ANALYSIS

12.9.3.REVENUE ANALYSIS

12.9.4.PRODUCT PORTFOLIO

12.9.5.RECENT DEVELOPEMENTS

12.9.6.DATA BRIDGE ANALYSIS

12.10.BIOSIMS TECHNOLOGIES

12.10.1.COMPANY OVERVIEW

12.10.2.SWOT ANALYSIS

12.10.3.REVENUE ANALYSIS

12.10.4.PRODUCT PORTFOLIO

12.10.5.RECENT DEVELOPEMENTS

12.10.6.DATA BRIDGE ANALYSIS

12.11. SIGNOSIS, INC.

12.11.1.COMPANY OVERVIEW

12.11.2.SWOT ANALYSIS

12.11.3.REVENUE ANALYSIS

12.11.4.PRODUCT PORTFOLIO

12.11.5.RECENT DEVELOPEMENTS

12.11.6.DATA BRIDGE ANALYSIS

13.APPENDIX

14.ABOUT DATA BRIDGE MARKET RESEARCH

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...